Abstract
Purpose
Rejection and possible infection with porcine pathogens are obstacles in clinical xenogeneic transplantation of porcine pancreatic islets (PPI) to treat diabetic patients. A solution to this problem could be microencapsulation of the PPI. However, isolation and microencapsulation are highly demanding tasks with considerable risks of damaging the PPI. Thus, it is not surprising that the long-term function (>200 days) of microencapsulated PPI (mPPI), transplanted to diabetic rats, has been observed only in a few cases.
Methods
Diabetes was induced in Wistar rats with streptozotozin (STZ 60 mg/kg body weight). Animals with consecutive blood glucose levels >300 mg/dl for more than 2 days were considered diabetic. PPI were isolated from brain-dead hybrid pigs (age 6–7 months or 2–3 years) using the Ricordi-technique and LiberasePI. After in vitro culture PPI were microencapsulated with highly purified barium–alginate and 1,000 mPPI of 300–500 μm ∅ were transplanted under the left kidney capsule and/or into the peritoneal cavity of STZ-diabetic rats (n = 15) without immunosuppression. Daily, later weekly, blood glucose level and body-weight were measured.
Results
mPPI showed normal glucose tolerance in vitro and also in vivo. Normoglycemia occurred between day 1 and 15 after transplantation. Four mPPI grafts functioned for more than 230 days, the longest now for >550 days. Three rats are currently normoglycemic for >40 days. Six rats lost xenograft function after 12–20 days, due to inflammatory reactions at the site of the grafts. Two xenografts failed to induce normoglycemia, because the capsules did not contain enough viable PPI.
Conclusions
Microencapsulated xenogeneic islets can induce long term normoglycemia in rats without immunosuppression. However, very often the grafts fail to control the blood glucose level adequately. The reasons for these failures are currently under investigation. Nevertheless, our results are very promising and might lead the way towards preclinical trials in non-human primates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Titus T, Badet L, Gray DWR (2000) Islet cell transplantation for insulin-dependent diabetes mellitus: perspectives from the present to the future. Exp Rev Mol Med. http://www-ermm.cbcu.cam.ac.uk/00001861h.htm, 6 September
Inoue K, Miyamoto M (2000) Islet transplantation. J Hepatobiliary Pancreat Surg 7:163–177
Cooper DKC, Kemp E, Platt JL, White DJG (1997) Xenotransplantation: the transplantation of organs and tissue between species. Springer, Berlin
Platt JL (2000) Immunobiology of xenotransplantation. Transpl Int Suppl 1:7–10
Tacke SJ, Kurth R, Denner J (2000) Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology 268:87–93
Loss M, Arends H, Winkler M, Przemeck M, Steinhoff G, Rensing S, Kaup FJ, Hedrich HJ, Winkler ME, Martin U (2001) Analysis of potential porcine endogenous retrovirus (PERV) transmission in a whole-organ xenotransplantation model without interfering microchimerism. Transpl Int 14:31–37
Sun Y, Ma X, Zhou D, Vavek I, Sun AM (1996) Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 6:1417–1422
Jain K, Asina S, Yang H, Blount ED, Smith BH, Diehl CH, Rubin AL (1999) Glucose control and long-term survival in biobreeding/Worcester rats after intraperitoneal implantation of hydrophilic macrobeads containing porcine islets without immunosuppression. Transplantation 68:1693–1700
Ricordi C, Finke EH, Lacy PE (1986) Method for the mass isolation of islets from the adult pig pancreas. Diabetes 35:649–653
Van der Burg MPM, Basir I, Bouwmann E (1998) No porcine islets loss during density gradient purification in a novel iodixanol in University of Wisconsin Solution. Transplant Proc 30:362
Krickhahn M, Meyer Th, Bühler C, Thiede A, Ulrichs K (2001) Highly efficient isolation of porcine islets of langerhans for xenotransplantation: numbers, purity, yield and in vitro function. Ann Transpl 6:48–54
Zekorn TDC, Bretzel RG (1999) Immunoprotection of islets of langerhans by microencapsulation in barium alginate beads. In: Kühtreiber WM, Lanza RP, Chick WL (eds) Cell encapsulation—technology and therapeutics. Birckhäuser, Berlin
Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A (2001) Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710–719
Zimmermann U, Klöck G, Federlin K, Hanning K, Kowalski M, Bretzel RG, Horcher A, Entemann AH (1992) Production of mitogen contamination free alginate with variable regions of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 13:269–274
Acknowledgments
The authors thank Dr. I. Chodnewska, Ms. S. Gahn, and Ms. L. Stevenson for their excellent technical assistence. The research described here is being supported by the Interdisciplinary Center for Clinical Research (IZKF) of the University of Wuerzburg (D3, research project grant number 01 KS 9603) and the grant no. 13019 from the Deutsche Bundesstiftung Umwelt.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meyer, T., Höcht, B. & Ulrichs, K. Xenogeneic islet transplantation of microencapsulated porcine islets for therapy of type I diabetes: long-term normoglycemia in STZ-diabetic rats without immunosuppression. Pediatr Surg Int 24, 1375–1378 (2008). https://doi.org/10.1007/s00383-008-2267-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-008-2267-9